CD4 and HIV infectious disease: Significantly, HIV‐specific CD4+ T cells expressing PD‐1 are enriched during chronic HIV infection, suggesting that targeting PD‐1 with antibodies may represent a potential strategy to address the latent viral reservoir [9].